2-Aminoindane: Difference between revisions
>Oskykins m Text replacement - "is currently thought to be a grey area compound within most parts of the world" to "is currently believed to be a grey area compound within most parts of the world" |
>Josikins m Text replacement - "NM2AI" to "NM-2-AI" |
||
Line 9: | Line 9: | ||
Very little is known about this substance, but it has recently become freely available through online [[research chemical]] vendors where it is being sold as a [[designer drug]]. | Very little is known about this substance, but it has recently become freely available through online [[research chemical]] vendors where it is being sold as a [[designer drug]]. | ||
==Chemistry== | ==Chemistry== | ||
2-AI, or 2-[[chemical class::Aminoindane]], is a structural analogue of [[amphetamine]]. It features the R<sub>3</sub> terminal carbon of the propane chain of amphetamine bound to the benzene ring. This creates an indane group, a bicyclic moeity containing a benzene ring fused to a pentane ring. 2-AI contains an amino group NH<sub>2</sub> bound to R<sub>2</sub> of the indane ring thus giving it the name 2-aminoindane. 2-AI is structurally analogous to | 2-AI, or 2-[[chemical class::Aminoindane]], is a structural analogue of [[amphetamine]]. It features the R<sub>3</sub> terminal carbon of the propane chain of amphetamine bound to the benzene ring. This creates an indane group, a bicyclic moeity containing a benzene ring fused to a pentane ring. 2-AI contains an amino group NH<sub>2</sub> bound to R<sub>2</sub> of the indane ring thus giving it the name 2-aminoindane. 2-AI is structurally analogous to NM-2-AI, lacking the N-substituted methyl group. | ||
==Pharmacology== | ==Pharmacology== |